Study With Rituximab, Cyclophosphamide, Doxorubicin Liposomal (Myocet®), Vincristine, Prednisone, (R-COMP) to Treat Non-Hodgkin's Lymphoma

Clinical trial NCT01009970 · UNKNOWN

Trial details

NCT number: NCT01009970
Sponsor: Fondazione Italiana Linfomi - ETS
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Diffuse Large B-Cell Lymphoma

Start date: 2010-05-01
Primary completion: 2011-05-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.